Loss of expression of the p16 gene is frequent in malignant skin tumors.
Expression of the p16 gene from 30 malignant skin tumors has been surveyed by immunohistochemical assay. Gene point mutations were detected by DNA direct sequencing and the mRNA level of gene expression was measured by RT-PCR. A silent point mutation of the p16 gene was found in only one patient. However, loss of expression of the p16 gene was noticed in 23 of 29 samples (79.3%). Correlation between loss of expression of the p16 gene and metastasis is significant (p = 0.0036). These findings suggest that loss of expression of the p16 gene may play a critical role in tumor progression of malignant skin tumors.
Chang
T G
TG
Institute of Life Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan, Republic of China.
Wang
J
J
Chen
L W
LW
Hsu
C Y
CY
Chang
H W
HW
Chen
J S
JS
Cho
C L
CL
D000230:Adenocarcinoma / Q000235:genetics; D002280:Basal Cell Carcinoma / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000235:genetics; D002352:Carrier Proteins / Q000032:analysis / Q000096:biosynthesis*; D019941:Cyclin-Dependent Kinase Inhibitor p16; D016147:Genes, Tumor Suppressor; D006394:Hemangiosarcoma / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry; D008545:Melanoma / Q000235:genetics; D009442:Neurilemmoma / Q000235:genetics; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D012878:Skin Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology
D002352:Carrier Proteins; D019941:Cyclin-Dependent Kinase Inhibitor p16; D012333:RNA, Messenger